BioScrip Reports Fourth Quarter 2013 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ELMSFORD, N.Y., Feb. 26, 2014 -- /PRNewswire/ -- BioScrip, Inc. (NASDAQ: BIOS) today announced 2013 fourth quarter financial results. Fourth quarter revenue from continuing operations was $243.5 million and the net loss from continuing operations was $15.4 million, or $0.23 per basic and diluted share.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC